Skip to main content
Caplight Logo









OneThree Biotech

OneThree Biotech

Private
New York City, New YorkHealthcare & Life Scienceshttps://onethree.bio

Last Round

Seed

Mar 26, 2020

Total Funding Raised

$2.68M

Company Overview

OneThree Biotech operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in March 2020.

OneThree Biotech is a biotechnology company that provides a biology-driven artificial intelligence platform to optimize pre-clinical drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

OneThree Biotech Comparables

Compare OneThree Biotech with similar companies based on industry and business-model similarity.

OneThree Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pepper Bio
88%
AI Vivo
85%
Unravel Biosciences
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

OneThree Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 26, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

OneThree Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 5, 2024

    Grew 100% QoQ from 4 to 8 employees.

  • Sep 28, 2024

    Grew 167% QoQ, from 3 to 8 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

OneThree Biotech Filings

Explore SEC and related filing metadata, where available.

OneThree Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about OneThree Biotech's valuation, stock price, and market status.

Is OneThree Biotech a public or private company?

OneThree Biotech is a private company.

What is the current stock price of OneThree Biotech?

OneThree Biotech is a private company, so its shares have no public market price. Caplight tracks OneThree Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is OneThree Biotech worth (valuation)?

Valuation information for OneThree Biotech is not publicly available.

Can I buy OneThree Biotech stock?

OneThree Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was OneThree Biotech's last funding round?

OneThree Biotech's most recent funding round was Seed on March 26, 2020.

Who are the main investors in OneThree Biotech?

Key investors in OneThree Biotech include Meridian Street Capital, Primary Venture Partners.

Will OneThree Biotech IPO soon?

No public IPO plans have been announced for OneThree Biotech.

How can I track OneThree Biotech secondary market activity?

Caplight tracks bids, offers, and trades in OneThree Biotech's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range7
Year Founded2018
Last FundingMar 26, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?